Contribution of vesicle trafficking dysregulation to the pathomechanism of mucopolysaccharidosis
Biochemical and Biophysical Research Communications · 2023-07 · 665 · 107-117
DOI: 10.1016/j.bbrc.2023.04.093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-07. Verfasst von Lidia Gaffke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, University of Gdansk, Wita Stwosza 59, 80-308, Gdansk, Poland. Hauptthemen laut MEDLINE: Mucopolysaccharidoses. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowym Centrum Nauki, Narodowe Centrum Nauki.
Abstract (Originalsprache)
Although mucopolysaccharidoses (MPS) are monogenic diseases, caused by mutations in genes coding for enzymes involved in degradation of glycosaminoglycans (GAGs), recent studies suggested that changes in expressions of various genes might cause secondary and tertiary cellular dysfunctions modulating the course of these diseases. In this report, we demonstrate that vesicle trafficking regulation is affected in fibroblasts derived from patients suffering from 11 different types of MPS due to changes in levels of crucial proteins (estimated by automated Western-blotting) involved in this process, including caveolin, clathrin, huntingtin (Htt), APPL1, EEA1, GOPC, Rab5, and Rab7. Microscopic studies confirmed these results, while investigations of tissue samples derived from the MPS I mouse model indicated differences between various organs in this matter. Moreover, transcriptomic analyses provided a global picture for changes in expressions of genes related to vesicle trafficking in MPS cells. We conclude that vesicle trafficking is dysregulated in MPS cells and changes in this process might contribute to the molecular mechanisms of this disease. Most probably, primary GAG storage might cause a cellular stress response leading to dysregulation of expression of many genes which, in turn, results in changes in cellular processes like vesicle trafficking. This can significantly modulate the course of the disease due to enhancing accumulation of GAGs and altering crucial cellular processes. This hypothesis has been supported by normalization of levels of clathrin in MPS cells treated with either an active form of the deficient GAG-degrading enzyme or a compound (5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) indirectly reducing the efficiency of GAG synthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, University of Gdansk, Wita Stwosza 59, 80-308, Gdansk, Poland.
- Department of Molecular Biology, University of Gdansk, Wita Stwosza 59, 80-308, Gdansk, Poland. Electronic address: grzegorz.wegrzyn@ug.edu.pl.
Förderung
- Narodowym Centrum Nauki
- Narodowe Centrum Nauki
Zitieren
APA
Gaffke, L., Pierzynowska, K., Cyske, Z., Podlacha, M., & Węgrzyn, G. (2023). Contribution of vesicle trafficking dysregulation to the pathomechanism of mucopolysaccharidosis. Biochemical and Biophysical Research Communications, 665, 107-117. https://doi.org/10.1016/j.bbrc.2023.04.093
Vancouver
Gaffke L, Pierzynowska K, Cyske Z, Podlacha M, Węgrzyn G. Contribution of vesicle trafficking dysregulation to the pathomechanism of mucopolysaccharidosis. Biochemical and Biophysical Research Communications. 2023;665:107-117. doi:10.1016/j.bbrc.2023.04.093
BibTeX
@article{Gaffke2023,
author = {Gaffke, Lidia and Pierzynowska, Karolina and Cyske, Zuzanna and Podlacha, Magdalena and Węgrzyn, Grzegorz},
title = {Contribution of vesicle trafficking dysregulation to the pathomechanism of mucopolysaccharidosis},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
volume = {665},
pages = {107--117},
doi = {10.1016/j.bbrc.2023.04.093}
}
EUVIMED